Published in J Med Genet on June 01, 1993
The human type I collagen mutation database. Nucleic Acids Res (1997) 2.02
Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A (2014) 1.70
Osteogenesis Imperfecta: A Review with Clinical Examples. Mol Syndromol (2011) 1.38
CRTAP mutations in lethal and severe osteogenesis imperfecta: the importance of combining biochemical and molecular genetic analysis. Eur J Hum Genet (2009) 1.07
Osteogenesis imperfecta: from phenotype to genotype and back again. Int J Exp Pathol (1994) 1.01
Osteopotentia regulates osteoblast maturation, bone formation, and skeletal integrity in mice. J Cell Biol (2010) 0.90
Osteogenesis imperfecta: a case report and review of literature. Ann Med Health Sci Res (2014) 0.75
Beneficial effects of dried pomegranate juice concentrated powder on ultraviolet B-induced skin photoaging in hairless mice. Exp Ther Med (2017) 0.75
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet (1984) 28.51
Genetic heterogeneity in osteogenesis imperfecta. J Med Genet (1979) 12.51
Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen. Am J Hum Genet (1988) 3.00
Detection of a high frequency RsaI polymorphism in the human pro alpha 2(I) collagen gene which is linked to an autosomal dominant form of osteogenesis imperfecta. EMBO J (1985) 2.52
Restriction fragment length polymorphism associated with the pro alpha 2(I) gene of human type I procollagen. Application to a family with an autosomal dominant form of osteogenesis imperfecta. J Clin Invest (1983) 2.50
Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta. J Biol Chem (1985) 2.45
Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta. Proc Natl Acad Sci U S A (1981) 2.28
Osteogenesis imperfecta: translation of mutation to phenotype. J Med Genet (1991) 2.26
Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2. Am J Hum Genet (1990) 2.11
Blot hybridisation analysis of genomic DNA. J Med Genet (1984) 2.09
Osteogenesis imperfecta is linked to both type I collagen structural genes. Lancet (1986) 2.07
The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta. J Med Genet (1984) 1.56
Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta. Am J Hum Genet (1990) 1.56
Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COL1A1). Am J Hum Genet (1990) 1.54
Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen. J Biol Chem (1987) 1.54
Polymorphism of DNA sequence in the human pro alpha 2(I) collagen gene. J Med Genet (1985) 1.53
The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen. J Biol Chem (1983) 1.52
Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent. Am J Hum Genet (1990) 1.47
Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype. J Clin Invest (1989) 1.45
Osteogenesis imperfecta type III. Delineation of the phenotype with reference to genetic heterogeneity. Am J Med Genet (1986) 1.17
Autosomal recessive inheritance of osteogenesis imperfecta. Clin Genet (1975) 1.14
Copy number of a human type I alpha 2 collagen gene. J Biol Chem (1982) 1.12
Isolation and characterization of a human pro alpha 2(I) collagen gene segment. J Invest Dermatol (1984) 1.08
Homozygous osteogenesis imperfecta unlinked to collagen I genes. Hum Genet (1988) 1.06
Osteogenesis imperfecta due to recurrent point mutations at CpG dinucleotides in the COL1A1 gene of type I collagen. Hum Genet (1991) 0.92
The effects of different cysteine for glycine substitutions within alpha 2(I) chains. Evidence of distinct structural domains within the type I collagen triple helix. J Biol Chem (1991) 0.86
Dominant mutations in familial lethal and severe osteogenesis imperfecta. Hum Genet (1991) 0.84
PCR detection of five restriction site dimorphisms at the type I collagen loci COL1A1 and COL1A2. Nucleic Acids Res (1991) 0.82
Clinical screening for collagen defects in connective tissue diseases. Clin Perinatol (1990) 0.80
On the paradoxically high relative prevalence of osteogenesis imperfecta type III in the black population of South Africa. Clin Genet (1985) 0.79
Matrix in cartilage and bone development: current views on the function and regulation of major organic components. Ann Med (1991) 0.78
Osteogenesis imperfecta type III: an ancient mutation in Africa? Am J Med Genet (1987) 0.78
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med (2000) 7.61
Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet (2001) 7.27
Tracing European founder lineages in the Near Eastern mtDNA pool. Am J Hum Genet (2000) 7.06
Articular mobility in an African population. Ann Rheum Dis (1973) 7.01
Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature (1996) 5.44
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet (2001) 4.97
The emerging tree of West Eurasian mtDNAs: a synthesis of control-region sequences and RFLPs. Am J Hum Genet (1999) 4.80
Paleolithic and neolithic lineages in the European mitochondrial gene pool. Am J Hum Genet (1996) 4.23
Orthopaedic aspects of the Ehlers-Danlos syndrome. J Bone Joint Surg Br (1969) 3.30
A signal, from human mtDNA, of postglacial recolonization in Europe. Am J Hum Genet (2001) 3.28
The estimation of two collagens from human dermis by interrupted gel electrophoresis. Biochem Biophys Res Commun (1976) 3.22
Altered relation of two collagen types in osteogenesis imperfecta. N Engl J Med (1977) 2.93
A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet (1999) 2.88
Correlation of procollagen mRNA levels in normal and transformed chick embryo fibroblasts with different rates of procollagen synthesis. Biochemistry (1978) 2.85
Defect in conversion of procollagen to collagen in a form of Ehlers-Danlos syndrome. Science (1973) 2.74
Detection of a high frequency RsaI polymorphism in the human pro alpha 2(I) collagen gene which is linked to an autosomal dominant form of osteogenesis imperfecta. EMBO J (1985) 2.52
Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II. Nature (1985) 2.46
Type I osteogenesis imperfecta: a nonfunctional allele for pro alpha 1 (I) chains of type I procollagen. Proc Natl Acad Sci U S A (1982) 2.45
Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta. J Biol Chem (1985) 2.45
Production of procollagen by human fibroblasts in culture. Proc Natl Acad Sci U S A (1972) 2.30
Epidemiology of fetal alcohol syndrome in a South African community in the Western Cape Province. Am J Public Health (2000) 2.30
A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome. N Engl J Med (1994) 2.29
Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta. Proc Natl Acad Sci U S A (1981) 2.28
Deletion of genes on chromosome 1 in endocrine neoplasia. Nature (1987) 2.27
Estimating Scandinavian and Gaelic ancestry in the male settlers of Iceland. Am J Hum Genet (2000) 2.22
Cytogenetic versus DNA diagnosis in routine referrals for fragile X syndrome. Lancet (1993) 2.20
Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum Mol Genet (1993) 2.16
A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature (1987) 2.15
Prenatal onset spinal muscular atrophy. Eur J Paediatr Neurol (1999) 2.15
Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2. Am J Hum Genet (1990) 2.11
Ancient bone DNA amplified. Nature (1989) 2.07
Osteogenesis imperfecta is linked to both type I collagen structural genes. Lancet (1986) 2.07
Radial ray defects and associated anomalies. Clin Genet (1989) 2.06
Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum. J Mol Med (Berl) (2000) 2.04
Rheumatoid arthritis in a rural South African Negro population. Ann Rheum Dis (1975) 2.03
Help! Unusual X-ray appearances of a congenital bone disease of unknown aetiology. Pediatr Radiol (2001) 2.01
Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27. Am J Hum Genet (2000) 1.98
Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene. Am J Hum Genet (1999) 1.98
Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn disease. J Med Genet (2007) 1.97
Waardenburg syndrome (WS) type I is caused by defects at multiple loci, one of which is near ALPP on chromosome 2: first report of the WS consortium. Am J Hum Genet (1992) 1.94
Preparation of type III procollagen and collagen from rat skin. Biochemistry (1974) 1.92
Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am J Hum Genet (1996) 1.89
Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet (1997) 1.89
Spontaneous multivessel cervical artery dissection in a patient with a substitution of alanine for glycine (G13A) in the alpha 1 (I) chain of type I collagen. Neurology (1996) 1.85
Cysteine in the triple-helical domain of one allelic product of the alpha 1(I) gene of type I collagen produces a lethal form of osteogenesis imperfecta. J Biol Chem (1984) 1.84
Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet (2001) 1.81
The bicuspid aortic valve: an integrated phenotypic classification of leaflet morphology and aortic root shape. Heart (2008) 1.81
mtDna and the islands of the North Atlantic: estimating the proportions of Norse and Gaelic ancestry. Am J Hum Genet (2001) 1.81
Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nat Genet (1999) 1.81
Marfan syndrome: abnormal alpha 2 chain in type I collagen. Proc Natl Acad Sci U S A (1981) 1.78
Medical genetics. Collagen and inherited connective tissue diseases. Nature (1983) 1.76
Osteoglophonic dwarfism. Pediatr Radiol (1980) 1.76
BiP binds type I procollagen pro alpha chains with mutations in the carboxyl-terminal propeptide synthesized by cells from patients with osteogenesis imperfecta. J Biol Chem (1993) 1.72
Surgical aspects of the Ehlers-Danlos syndrome. A survey of 100 cases. Br J Surg (1969) 1.72
Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet (1998) 1.72
Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta. J Clin Invest (1983) 1.71
Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts. J Clin Invest (1992) 1.68
Identification of the collagenous proteins synthesized by cultured cells from human skin. Biochemistry (1975) 1.67
Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele. Proc Natl Acad Sci U S A (1986) 1.65
Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene. Am J Med Genet (1996) 1.65
The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat Genet (2000) 1.64
Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature (1990) 1.64
The clinical features of sclerosteosis. A review of the manifestations in twenty-five affected individuals. Ann Intern Med (1976) 1.63
X-linked cutis laxa: defective cross-link formation in collagen due to decreased lysyl oxidase activity. N Engl J Med (1980) 1.62
mtDNA suggests Polynesian origins in Eastern Indonesia. Am J Hum Genet (1998) 1.62
Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I. J Clin Invest (1990) 1.61
High frequency of large intragenic deletions in the Fanconi anemia group A gene. Am J Hum Genet (1999) 1.60
Genetic influences in end-stage osteoarthritis. Sibling risks of hip and knee replacement for idiopathic osteoarthritis. J Bone Joint Surg Br (1997) 1.60
Osteogenesis imperfecta: update and perspective. Am J Med Genet (1984) 1.60
Genetic evidence for a family-based Scandinavian settlement of Shetland and Orkney during the Viking periods. Heredity (Edinb) (2005) 1.59
Variants of the Ehlers-Danlos syndrome. Clinical, biochemical, haematological, and chromosomal features of 100 patients. Ann Rheum Dis (1969) 1.59
The syndromic status of sclerosteosis and van Buchem disease. Clin Genet (1984) 1.58
The natural history of sclerosteosis. Clin Genet (2003) 1.58
Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV. Am J Hum Genet (2001) 1.58
Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet (2000) 1.58
Rheumatic disorders in the South African Negro. Part II. Osteo-arthrosis. S Afr Med J (1975) 1.57
Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet (1999) 1.57
Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta. Am J Hum Genet (1990) 1.56
A new locus for autosomal dominant retinitis pigmentosa on the short arm of chromosome 17. Hum Mol Genet (1994) 1.56
Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis. J Med Genet (1996) 1.55
Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COL1A1). Am J Hum Genet (1990) 1.54
A review of the osteopetroses. Postgrad Med J (1977) 1.53
Polymorphism of DNA sequence in the human pro alpha 2(I) collagen gene. J Med Genet (1985) 1.53
Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations. J Med Genet (2009) 1.53
Vestibular dysfunction in hereditary ataxia. Brain (1975) 1.53
Intron-mediated recombination may cause a deletion in an alpha 1 type I collagen chain in a lethal form of osteogenesis imperfecta. Proc Natl Acad Sci U S A (1985) 1.53
Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen. Am J Hum Genet (1994) 1.51
A nonsense mutation and exon skipping in the Fanconi anaemia group C gene. Hum Mol Genet (1993) 1.51
Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet (2000) 1.51
Nijmegen breakage syndrome diagnosed as Fanconi anaemia. Pediatr Blood Cancer (2005) 1.50
Sclerosteosis - an autosomal recessive disorder. Clin Genet (1977) 1.50
Patterns of cognitive-motor development in children with fetal alcohol syndrome from a community in South Africa. Alcohol Clin Exp Res (2001) 1.49
Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I) chain of type I collagen result in defective chain association and produce lethal osteogenesis imperfecta. J Biol Chem (1993) 1.49
The dominant and recessive forms of cutis laxa. J Med Genet (1972) 1.48
Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent. Am J Hum Genet (1990) 1.47
Altered secretion of type III procollagen in a form of type IV Ehlers-Danlos syndrome. Biochemical studies in cultured fibroblasts. Lab Invest (1981) 1.46
A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito. Nat Genet (1996) 1.46